Cerebellar Transcranial Direct Current Stimulation (tDCS) in Patients With Isolated Cervical Dystonia (CD)

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

20 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-09-15

Study Completion Date

2025-12-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Cervical dystonia (CD) is a movement disorder characterized by involuntary muscle contractions of the neck, leading to abnormal head postures and movement, pain and impaired motor function. Current treatments for CD, such as botulinum toxin injections and physical therapy, may not always provide sufficient relief of symptoms and may fail to offer long-term benefits for patients. As a result, new therapeutic approaches are needed. Transcranial direct current stimulation (tDCS) is a non-invasive brain stimulation technique that modulates neuronal activity. Recent neurophysiological studies suggest that cerebellar tDCS (ctDCS), in particular, could be beneficial in modulating the activity of the sensorimotor network in CD. This clinical trial aims to investigate the effects of ctDCS on the excitability of the sensorimotor network and motor symptom severity in CD patients. Applying transcranial magnetic stimulation (TMS) we will evaluate the effects of anodal, cathodal and sham ctDCS to improve the understanding of the neurophysiological mechanisms underlying CD and the potential therapeutic role of ctDCS.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

tDCS in Cervical Dystonia

NCT02180139

Cervical Dystonia

WITHDRAWN NA

Computer Modelling of the Cervical Spine Movements in Cervical Dystonia

NCT02894359

Cervical Dystonia, Primary

COMPLETED

Identification of Optimal Stimulation Site for Cervical Dystonia Symptoms: An Exploratory Study

NCT01859247

Cervical Dystonia Spasmodic Torticollis

COMPLETED NA

Integration of the Cervical Proprioceptive Signals in Patients With Cervical Dystonia

NCT02834871

Cervical Dystonia

COMPLETED NA

Non-Motor Features of Cervical Dystonia (CD)

NCT03471923

Cervical Dystonia Movement Disorders Focal Dystonia +5 more

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Dystonia is a movement disorder characterized by involuntary, sustained or intermittent muscle contractions, resulting in abnormal movements and postures. CD is the most common form of focal dystonia. It is characterized by abnormal postures or movements of the head. Standard treatment in patients with CD includes regular botulinum toxin injections and physical therapy, but many patients continue to experience symptoms, especially towards the end of the treatment cycle, highlighting the need for alternative treatment options.

One of the challenges in treating CD is the incomplete understanding of its underlying neurophysiological mechanisms. Recently, CD has been recognized as a network disorder, affecting the basal ganglia, the brainstem, the sensorimotor cortex and the cerebellum. So far, there is increasing evidence supporting the role of the cerebellum in the pathophysiology of dystonia, including animal models, neuroimaging and neurophysiological studies, but the exact the role in the proposed dystonia network is only incompletely understood.

TDCS is a form of non-invasive brain stimulation modulating the excitability of superficially located neurons. CtDCS is known to modulate the excitability of neurons of the cerebellar cortex, while the cerebellar nuclei and the brain stem remain unaffected. It has been shown that anodal ctDCS increases and cathodal ctDCS decreases the excitability of the cerebellum.

This randomized and sham-controlled clinical trial aims to investigate the effects of anodal and cathodal ctDCS in CD patients, focusing on both the sensorimotor network excitability and motor symptom severity. Participants will undergo three separated experimental sessions separated by one week, each with a different stimulation condition: anodal, cathodal, and sham ctDCS. Both, the study participants and the experimenter will be blinded to the order of stimulation mode.

The outcome measures will include:

1. Changes in the sensorimotor network before and after ctDCS stimulation, assessed by TMS. Measurements include four main metrics to determine the neurophysiological properties of the sensorimotor network in different ways:

1. Single-pulse TMS (SP-TMS) of the left primary motor cortex, used to quantify the amplitude of motor-evoked potentials (MEPs) in response to unconditioned stimuli,
2. Short-interval intracortical inhibition (SICI),
3. Short-latency afferent inhibition (SAI),
4. Cerebellar brain inhibition (CBI).
2. Clinical motor symptom severity, assessed with the Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS) before and after each session.

This study aims to improve the understanding of the neurophysiological mechanisms and clinical effects of ctDCS in isolated CD.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Isolated Cervical Dystonia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Double blind

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Anodal ctDCS

Patients receive anodal ctDCS stimulation for 20 minutes with 2 mA

Group Type ACTIVE_COMPARATOR

Anodal and cathodal ctDCS

Intervention Type DEVICE

CtDCS will be delivered using an DC-stimulator and two saline-soaked sponge electrodes: one electrode placed 3 cm lateral to the right of the inion, the other electrode on the right buccinator muscle. A 2 mA current will be delivered through these electrodes for a duration of 20 minutes with a 8-second fade-in and fade-out.

Cathodal ctDCS

Patients receive cathodal ctDCS stimulation for 20 minutes with 2 mA

Group Type ACTIVE_COMPARATOR

Anodal and cathodal ctDCS

Intervention Type DEVICE

CtDCS will be delivered using an DC-stimulator and two saline-soaked sponge electrodes: one electrode placed 3 cm lateral to the right of the inion, the other electrode on the right buccinator muscle. A 2 mA current will be delivered through these electrodes for a duration of 20 minutes with a 8-second fade-in and fade-out.

Sham stimulation

Patients receive ctDCS stimulation for 20 minutes with 0 mA

Group Type SHAM_COMPARATOR

Sham stimulation

Intervention Type DEVICE

The tDCS procedure will be identical to the active (anodal and cathodal) stimulation condition, but stimulation will cease after 30 seconds.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Anodal and cathodal ctDCS

CtDCS will be delivered using an DC-stimulator and two saline-soaked sponge electrodes: one electrode placed 3 cm lateral to the right of the inion, the other electrode on the right buccinator muscle. A 2 mA current will be delivered through these electrodes for a duration of 20 minutes with a 8-second fade-in and fade-out.

Intervention Type DEVICE

Sham stimulation

The tDCS procedure will be identical to the active (anodal and cathodal) stimulation condition, but stimulation will cease after 30 seconds.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Clinical diagnosis of isolated cervical dystonia
* Written informed consent by the patient

Exclusion Criteria

* History of other neurological disorders other than CD
* Secondary dystonia
* Severe head tremor
* Intake of centrally acting medication
* Contraindications to TMS, such as metallic implants, pregnancy and history of seizures

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No